RoeleveldPPde KlerkJCA. The perspective of the intensivist on inotropes and postoperative care following pediatric heart surgery: an international survey and systematic review of the literature. World J Pediatr Congenit Heart Surg. 2018;9(1):10–21.
2.
AltenJABorasinoSTomsR. Early initiation of arginine vasopressin infusion in neonates after complex cardiac surgery. Pediatr Crit Care Med. 2012;13(3):300–304.
3.
MastropietroCWClarkJADeliusRE. Arginine vasopressin to manage hypoxemic infants after stage 1 palliation of single ventricle lesions. Pediatr Crit Care Med. 2008;9(5):506–510.
4.
MastropietroCWDavalosMCSeshadriSWaltersHLIIIDeliusRE. Clinical response to arginine vasopressin therapy after paediatric cardiac surgery. Cardiol Young. 2013;23(3):387–393.
5.
MoralesDLGreggDHelmanDN. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000;69(1):102–106.
6.
MatokIRubinsteinMLevyA. Terlipressin for children with extremely low cardiac output after open heart surgery. Ann Pharmacother. 2009;43(3):423–429.
7.
RosensweigEBStarcTJChenJW. Intravenous arginine vasopressin in children with vasodilatory shock after cardiac surgery. Circulation. 1999;100(19 suppl):1182–1186.
8.
TayamaEUedaTShojimaT. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg. 2007;6(6):715–719.
9.
BurtonGLKaufmanJGootBHda CruzEM. The use of arginine vasopressin in neonates following the Norwood procedure. Cardiol Young. 2011;21(5):536–544.
10.
PellitierJSDickensBBigamD. Cardiac effects of vasopressin. J Cardiovasc Pharmacol. 2014;64(1):100–107.
